Skip to main content
. 2002 Feb;13(2):445–453. doi: 10.1091/mbc.01-04-0211

Table 1.

Silencing efficiency in wild type and RdRP mutant cells

Host strain transformation AX2
RrpA
DosA
β-Gal + control
β-Gal + mcRNAi
β-Gal + control
β-Gal + mcRNAi
β-Gal + control
β-Gal + mcRNAi
Clone 1A 128 Clone 2A 6,1 Clone 3A 378 Clone 4A 10,2 Clone 5A 1257 Clone 6A 4,4
Clone 1B 383 Clone 2B 8,9 Clone 3B 255 Clone 4B 74 Clone 5B 90 Clone 6B 8,8
Clone 1C 457 Clone 2C 1,0 Clone 3C 23,2 Clone 4C 24,3 Clone 5C 1024 Clone 6C 14,9
Clone 1D 155 Clone 2D 0,6 Clone 3D 246 Clone 4D 343 Clone 5D 233 Clone 6D 3,6
Clone 1E 293 Clone 3E 26 Clone 4E 89 Clone 5E 838 Clone 6E 1,8
Clone 3F 334 Clone 4F 163 Clone 5F 413 Clone 6F 22,6
Clone 3G 83 Clone 4G 656 Clone 5G 1184 Clone 6G 5,3
Clone 3H 319 Clone 4H 16,4 Clone 5H 1271 Clone 6H 1,11
Clone 3I 24 Clone 4I 140 Clone 5I 1063 Clone 6I 23,0
Clone 3J 200 Clone 4J 509 Clone 5J 663 Clone 6J 4,6
Population 316 Population 8,2 Population 210 Population 253 Population 419 Population 15,1
Average β-gal activity (U/mg) clones + pop. 289 ± 128 5 ± 4 191 ± 132 207 ± 214 769 ± 428 9, 6 ± 8
Unpaired t test p value 0,0008 0,83 0,0001
Average reduction by RNAi 98% 0% 99%
HHS Vulnerability Disclosure